Felipe Montano-Campos
@jfelipemcampos.bsky.social
Health Econ and Decision Science at UW
Brought economic theory into cost-effectiveness & decision science 💡 New paper in PharmacoEconomics – Open: When prevention treatments change behavior, they can change their own value — and we need to capture that. Even with riskier behavior, long-acting PrEP stays cost-effective. ✅
Treatment (as Prevention) Availability and Individuals’ Behavior: A Cost-Effectiveness Analysis of Cabotegravir Long-Acting Injectable PrEP - PharmacoEconomics - Open
Background The US Food and Drug Administration (FDA) has approved long-acting injectable agents for preexposure prophylaxis (PrEP) of human immunodeficiency virus (HIV) infection. These agents are urg...
doi.org
August 12, 2025 at 4:03 PM
Brought economic theory into cost-effectiveness & decision science 💡 New paper in PharmacoEconomics – Open: When prevention treatments change behavior, they can change their own value — and we need to capture that. Even with riskier behavior, long-acting PrEP stays cost-effective. ✅